• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较缓释安非他酮戒烟中获益框架信息与损失框架信息:一项随机对照试验。

Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.

作者信息

Toll Benjamin A, O'Malley Stephanie S, Katulak Nicole A, Wu Ran, Dubin Joel A, Latimer Amy, Meandzija Boris, George Tony P, Jatlow Peter, Cooney Judith L, Salovey Peter

机构信息

Yale University School of Medicine, Department of Psychiatry, New Haven, CT 06511, USA.

出版信息

Psychol Addict Behav. 2007 Dec;21(4):534-44. doi: 10.1037/0893-164X.21.4.534.

DOI:10.1037/0893-164X.21.4.534
PMID:18072836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527727/
Abstract

Prospect theory suggests that because smoking cessation is a prevention behavior with a fairly certain outcome, gain-framed messages will be more persuasive than loss-framed messages when attempting to encourage smoking cessation. To test this hypothesis, the authors randomly assigned participants (N=258) in a clinical trial to either a gain- or loss-framed condition, in which they received factually equivalent video and printed messages encouraging smoking cessation that emphasized either the benefits of quitting (gains) or the costs of continuing to smoke (losses), respectively. All participants received open label sustained-release bupropion (300 mg/day) for 7 weeks. In the intent-to-treat analysis, the difference between the experimental groups by either point prevalence or continuous abstinence was not statistically significant. Among 170 treatment completers, however, a significantly higher proportion of participants were continuously abstinent in the gain-framed condition as compared with the loss-framed condition. These data suggest that gain-framed messages may be more persuasive than loss-framed messages in promoting early success in smoking cessation for participants who are engaged in treatment.

摘要

前景理论表明,由于戒烟是一种结果相当确定的预防行为,因此在试图鼓励戒烟时,采用获益框架的信息比采用损失框架的信息更具说服力。为了验证这一假设,作者在一项临床试验中,将参与者(N = 258)随机分配到获益框架组或损失框架组,在这两组中,他们分别收到内容基本相同的视频和印刷信息,这些信息鼓励戒烟,分别强调了戒烟的益处(获益)或继续吸烟的代价(损失)。所有参与者均接受为期7周的开放标签缓释安非他酮(300毫克/天)治疗。在意向性分析中,无论是按点患病率还是持续戒烟率计算,实验组之间的差异均无统计学意义。然而,在170名完成治疗的参与者中,与损失框架组相比,获益框架组中持续戒烟的参与者比例显著更高。这些数据表明,对于正在接受治疗的参与者,在促进戒烟早期成功方面,采用获益框架的信息可能比采用损失框架的信息更具说服力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/3e96979e278e/nihms52647f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/93fd27c550ca/nihms52647f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/dbb98d9ef21b/nihms52647f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/3e96979e278e/nihms52647f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/93fd27c550ca/nihms52647f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/dbb98d9ef21b/nihms52647f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6429/2527727/3e96979e278e/nihms52647f3.jpg

相似文献

1
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.比较缓释安非他酮戒烟中获益框架信息与损失框架信息:一项随机对照试验。
Psychol Addict Behav. 2007 Dec;21(4):534-44. doi: 10.1037/0893-164X.21.4.534.
2
Message framing for smoking cessation: the interaction of risk perceptions and gender.戒烟的信息框架:风险认知与性别的相互作用。
Nicotine Tob Res. 2008 Jan;10(1):195-200. doi: 10.1080/14622200701767803.
3
Randomized trial: Quitline specialist training in gain-framed vs standard-care messages for smoking cessation.随机试验:戒烟热线专家培训使用增益框架与标准护理信息进行戒烟。
J Natl Cancer Inst. 2010 Jan 20;102(2):96-106. doi: 10.1093/jnci/djp468. Epub 2010 Jan 7.
4
Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.缓释安非他酮用于非裔美国人戒烟:一项随机对照试验。
JAMA. 2002;288(4):468-74. doi: 10.1001/jama.288.4.468.
5
A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.纳曲酮增强安非他酮戒烟并减少体重增加的初步研究。
Addict Behav. 2008 Jan;33(1):173-9. doi: 10.1016/j.addbeh.2007.05.012. Epub 2007 Jun 2.
6
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.伐尼克兰(一种α4β2烟碱型乙酰胆碱受体部分激动剂)与安慰剂或缓释安非他酮用于戒烟的疗效:一项随机对照试验。
JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56.
7
A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.一项多中心、随机、双盲、安慰剂对照的为期6个月的试验,旨在研究盐酸安非他酮缓释片对医院员工戒烟的辅助作用。
Nicotine Tob Res. 2004 Feb;6(1):55-61. doi: 10.1080/14622200310001656867.
8
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.伐尼克兰(一种α4β2烟碱型乙酰胆碱受体部分激动剂)与缓释安非他酮及安慰剂用于戒烟的随机对照试验
JAMA. 2006 Jul 5;296(1):47-55. doi: 10.1001/jama.296.1.47.
9
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.伐尼克兰、缓释安非他酮或安慰剂成功治疗的吸烟者中立即戒烟与延迟戒烟及复发率的比较
Addiction. 2010 Nov;105(11):2002-13. doi: 10.1111/j.1360-0443.2010.03058.x. Epub 2010 Sep 1.
10
Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.参与丁胺苯丙酮临床试验的非裔美国轻度吸烟者戒烟的预测因素。
Addict Behav. 2013 Mar;38(3):1796-803. doi: 10.1016/j.addbeh.2012.11.010. Epub 2012 Nov 29.

引用本文的文献

1
"To reach the new generation… TikTok:" Applying behavioral economics to adolescent and young adult HIV pre-exposure prophylaxis education.“面向新一代……TikTok:将行为经济学应用于青少年和青年成人的艾滋病病毒暴露前预防教育。”
Patient Educ Couns. 2025 Jul 25;140:109277. doi: 10.1016/j.pec.2025.109277.
2
COVID-19 memorable messages as internal narratives: stability and change over time.作为内部叙事的新冠疫情记忆信息:随时间的稳定性与变化
Policy Sci. 2024 Sep;57(3):519-538. doi: 10.1007/s11077-024-09538-5. Epub 2024 Jul 8.
3
CLINICO-HISTOPATHOLOGIC PRESENTATION OF A NIGERIAN CHILD WITH TORSION OF A TESTICULAR APPENDAGE: A CASE REPORT.一名尼日利亚儿童睾丸附件扭转的临床病理表现:病例报告
Ann Ib Postgrad Med. 2024 Dec 31;22(3):127-129.
4
Baseline physical activity moderates brain-behaviour relationships in response to framed health messages.基线身体活动会调节对框架化健康信息的脑-行为关系。
Soc Cogn Affect Neurosci. 2025 May 30;20(1). doi: 10.1093/scan/nsaf046.
5
Gain-Framed Text Messages and Nicotine Replacement Therapy for Smoking Cessation Among Lung Cancer Screening Patients: A Brief Report of a Pilot Randomized Controlled Trial.肺癌筛查患者中用于戒烟的获益框架文本信息与尼古丁替代疗法:一项试点随机对照试验的简要报告
Int J Environ Res Public Health. 2025 Apr 2;22(4):543. doi: 10.3390/ijerph22040543.
6
Examination of a hope- and fear-based message targeting older adults who smoke: A randomized trial.针对老年吸烟者的基于希望和恐惧的信息的检验:一项随机试验。
Geriatr Nurs. 2024 Nov-Dec;60:533-540. doi: 10.1016/j.gerinurse.2024.10.010. Epub 2024 Oct 22.
7
Qualitative Message Development to Motivate Quitting Smoking in Older Adults: Dementia May Motivate Quitting.为鼓励老年人戒烟而开展的定性信息开发:痴呆症可能成为戒烟的动力。
Inquiry. 2024 Jan-Dec;61:469580241236416. doi: 10.1177/00469580241236416.
8
Efficacy of Digital Outreach Strategies for Collecting Smoking Data: Pragmatic Randomized Trial.数字外展策略收集吸烟数据的效果:实用随机试验
JMIR Form Res. 2024 Feb 9;8:e50465. doi: 10.2196/50465.
9
Validation of Mobile Messages for an mHealth Intervention for Smokeless Tobacco Cessation in India.验证针对印度无烟烟草戒断的移动信息干预措施的有效性。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4011-4015. doi: 10.31557/APJCP.2023.24.12.4011.
10
Antidepressants for smoking cessation.抗抑郁药戒烟。
Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6.

本文引用的文献

1
Why are you bringing up condoms now? The effect of message content on framing effects of condom use messages.你为什么现在提起避孕套?信息内容对避孕套使用信息框架效应的影响。
Health Psychol. 2005 May;24(3):321-6. doi: 10.1037/0278-6133.24.3.321.
2
Promoting exercise behaviour: an integration of persuasion theories and the theory of planned behaviour.促进运动行为:说服理论与计划行为理论的整合
Br J Health Psychol. 2004 Nov;9(Pt 4):505-21. doi: 10.1348/1359107042304605.
3
Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.无论有无安非他酮,戒烟方面是否存在性别差异?对缓释安非他酮临床试验的汇总分析和荟萃分析。
Addiction. 2004 Nov;99(11):1462-9. doi: 10.1111/j.1360-0443.2004.00845.x.
4
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.安非他酮缓释片与实际戒烟咨询:结局的预测因素
Nicotine Tob Res. 2003 Dec;5(6):911-21. doi: 10.1080/14622200310001646903.
5
Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.安非他酮缓释剂在医疗环境中用于戒烟的有效性:一项随机试验。
Arch Intern Med. 2003 Oct 27;163(19):2337-44. doi: 10.1001/archinte.163.19.2337.
6
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.一项关于安非他酮缓释片戒烟的多中心、随机、双盲、安慰剂对照的1年研究。
J Intern Med. 2003 Aug;254(2):184-92. doi: 10.1046/j.1365-2796.2003.01185.x.
7
Measures of abstinence in clinical trials: issues and recommendations.临床试验中的禁欲测量:问题与建议。
Nicotine Tob Res. 2003 Feb;5(1):13-25.
8
Psychological intervention and antidepressant treatment in smoking cessation.戒烟中的心理干预与抗抑郁治疗。
Arch Gen Psychiatry. 2002 Oct;59(10):930-6. doi: 10.1001/archpsyc.59.10.930.
9
Enhancing the effectiveness of tobacco package warning labels: a social psychological perspective.从社会心理学角度提高烟草包装警示标签的有效性
Tob Control. 2002 Sep;11(3):183-90. doi: 10.1136/tc.11.3.183.
10
Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.缓释安非他酮用于非裔美国人戒烟:一项随机对照试验。
JAMA. 2002;288(4):468-74. doi: 10.1001/jama.288.4.468.